Molecular Approach to Allergy Diagnosis and Therapy
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Presently, allergy diagnosis and therapy procedures are undergoing a transition phase in which allergen extracts are being step-by-step replaced by molecule-based products. The new developments will allow clinicians to obtain detailed information on sensitization patterns, more accurate interpretation of allergic symptoms, and thus improved patients' management. In this respect, recombinant technology has been applied to develop this new generation of molecule-based allergy products. The use of recombinant allergens allows full validation of identity, quantity, homogeneity, structure, aggregation, solubility, stability, IgE-binding and the biologic potency of the products. In contrast, such parameters are extremely difficult to assay and standardize for extract-based products. In addition to the possibility of bulk production of wild type molecules for diagnostic purposes, recombinant technology opened the possibility of developing safer and more efficacious products for allergy therapy. A number of molecule-based hypoallergenic preparations have already been successfully evaluated in clinical trials, bringing forward the next generation of allergy vaccines. In this contribution, we review the latest developments in allergen characterization, molecule-based allergy diagnosis, and the application of recombinant allergens in therapeutic setups. A comprehensive overview of clinical trials using recombinant allergens as well as synthetic peptides is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Arbes Jr., S. J., Gergen, P. J., Elliott, L., & Zeldin, D. C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.017 · Cited by 639
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics
Canonica, G. W., Ansotegui, I. J., Pawankar, R., Schmid-Grendelmeier, P., van Hage, M., Baena-Cagnani, C. E., Melioli, G., Nunes, C., Passalacqua, G., Rosenwasser, L., et al. (2013) · World Allergy Organization Journal · doi:10.1186/1939-4551-6-17 · Cited by 432
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Senti, G., Crameri, R., Kuster, D., Johansen, P., Martinez-Gomez, J. M., Graf, N., Steiner, M., Hothorn, L. A., Grönlund, H., Tivig, C., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.026 · Cited by 271
Patel, D., Couroux, P., Hickey, P., Salapatek, A. M., Laidler, P., Larché, M., & Hafner, R. P. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.028 · Cited by 198
Curin, M., Reininger, R., Swoboda, I., Focke, M., Valenta, R., & Spitzauer, S. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000321113 · Cited by 107
Bronnert, M., Mancini, J., Birnbaum, J., Agabriel, C., Liabeuf, V., Porri, F., Cleach, I., Fabre, A., Deneux, I., Grandné, V., et al. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04035.x · Cited by 94
Meyer, W., Narkus, A., Salapatek, A. M., & Häfner, D. (2013) · Allergy · doi:10.1111/all.12148 · Cited by 72
Cited by
The algal chloroplast as a synthetic biology platform for production of therapeutic proteins
Dyo, Y. M., & Purton, S. (2018) · Microbiology · doi:10.1099/mic.0.000599 · Cited by 140
Pollen Allergens for Molecular Diagnosis
Pablos, I., Wildner, S., Asam, C., Wallner, M., & Gadermaier, G. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0603-z · Cited by 71
Self-citationAllergens of Blomia tropicalis: An Overview of Recombinant Molecules
Santos da Silva, E., Asam, C., Lackner, P., Hofer, H., Wallner, M., Silva Pinheiro, C., Alcântara-Neves, N. M., & Ferreira, F. (2017) · International Archives of Allergy and Immunology · doi:10.1159/000464325 · Cited by 48
Self-citationKim, H. H., Lee, C. S., Yu, S. D., Lee, J. S., Chang, J. Y., Jeon, J. M., Son, H. R., Park, C. J., Shin, D. C., & Lim, Y. W. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.3.698 · Cited by 30
Metadata
- Authors
- Ferreira, F., Wolf, M., & Wallner, M.
- Venue
- Yonsei Medical Journal
- Publisher
- XMLink
- Published
- 2014
- Volume
- 55
- Issue
- 4
- Pages
- 839
- ISSN
- 0513-5796 (ISSN-L)
- 1976-2437
- OpenAlex
- W2122638190
- Cited by
- 46
- References
- 8
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.